Metformin-Loaded Chitosan Hydrogels Suppress Bladder Tumor Growth in an Orthotopic Mouse Model via Intravesical Administration
Molecules · 2023
DOI: 10.3390/molecules28186720 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, 2023. Verfasst von Xingjian Zhang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Study and Discovery of Small Targeted Molecules of Hunan Province, Key Laboratory of Chemical Biology & Traditional Chinese Medicin…. Hauptthemen laut MEDLINE: Chitosan, Metformin, Urinary Bladder Neoplasms. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The National Natural Science Foundation of China, Institutional Open Fund, Key Project of Developmental Biology and Breeding from Hunan Province.
Abstract (Originalsprache)
Our previous study found that the intravesical perfusion of metformin has excellent inhibitory effects against bladder cancer (BC). However, this administration route allows the drug to be diluted and excreted in urine. Therefore, increasing the adhesion of metformin to the bladder mucosal layer may prolong the retention time and increase the pharmacological activity. It is well known that chitosan (Cs) has a strong adhesion to the bladder mucosal layer. Thus, this study established a novel formulation of metformin to enhance its antitumor activity by extending its retention time. In this research, we prepared Cs freeze-dried powder and investigated the effect of metformin-loaded chitosan hydrogels (MLCH) in vitro and in vivo. The results showed that MLCH had a strong inhibitory effect against proliferation and colony formation in vitro. The reduction in BC weight and the expression of tumor biomarkers in orthotopic mice showed the robust antitumor activity of MLCH via intravesical administration in vivo. The non-toxic profile of MLCH was observed as well, using histological examinations. Mechanistically, MLCH showed stronger functional activation of the AMPKα/mTOR signaling pathway compared with metformin alone. These findings aim to make this novel formulation an efficient candidate for managing BC via intravesical administration.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Key Laboratory of Study and Discovery of Small Targeted Molecules of Hunan Province, Key Laboratory of Chemical Biology & Traditional Chinese Medicine Research of Ministry of Education, Department of Pharmacy, School of…
- Key Laboratory of Protein Chemistry and Developmental Biology of Fish of Ministry of Education, Hunan Normal University, Changsha 410205, China.
ORCID-Profile: Xiaoping Yang
Förderung
- The National Natural Science Foundation of China
- Institutional Open Fund
- Key Project of Developmental Biology and Breeding from Hunan Province
- Natural Science Foundation of Changsha
- Graduate Scientific Research Innovation Project of Hunan Province, China
- National Natural Science Foundation of China
- Hunan province college students research learning and innovative experiment project
Zitieren
APA
Zhang, X., Hu, X., Xie, Y., Xie, L., Chen, X., Peng, M., Li, D., Deng, J., Xiao, D., & Yang, X. (2023). Metformin-Loaded Chitosan Hydrogels Suppress Bladder Tumor Growth in an Orthotopic Mouse Model via Intravesical Administration. Molecules. https://doi.org/10.3390/molecules28186720
Vancouver
Zhang X, Hu X, Xie Y, Xie L, Chen X, Peng M, et al. Metformin-Loaded Chitosan Hydrogels Suppress Bladder Tumor Growth in an Orthotopic Mouse Model via Intravesical Administration. Molecules. 2023. doi:10.3390/molecules28186720
BibTeX
@article{Zhang2023,
author = {Zhang, Xingjian and Hu, Xin and Xie, Yijun and Xie, Lejing and Chen, Xiangyi and Peng, Mei and Li, Duo and Deng, Jun and Xiao, Di and Yang, Xiaoping},
title = {Metformin-Loaded Chitosan Hydrogels Suppress Bladder Tumor Growth in an Orthotopic Mouse Model via Intravesical Administration},
journal = {Molecules},
year = {2023},
doi = {10.3390/molecules28186720}
}
EUVIMED